Your session is about to expire
← Back to Search
CARE + COACH for Breast Cancer Screening
N/A
Recruiting
Led By Allison Barlow, PhD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
Study Summary
This trial will evaluate if providing culturally tailored mammography education & patient navigator support helps White Mountain Apache women get mammograms when referred.
Who is the study for?
This trial is for American Indian or Alaska Native women who need a mammogram and live near the Fort Apache Indian Reservation. They can't have had a mammogram in the last year, a personal history of breast cancer, plans to move soon, or be unwilling to be randomly assigned to a group.Check my eligibility
What is being tested?
The study compares two ways to encourage breast cancer screening: CARE (a tailored education module) and CARE+COACH (CARE plus help from an Apache health coach). Women will be put into one of these groups by chance.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medications, there are no direct medical side effects. However, participants may experience anxiety or discomfort related to discussing medical procedures.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am female.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Mammography uptake
Trial Design
2Treatment groups
Experimental Treatment
Group I: CARE - Intervention arm for mammography educationExperimental Treatment1 Intervention
CARE is a culturally tailored mammography education module.
Group II: CARE + COACH - Intervention arm for mammography education + a patient navigatorExperimental Treatment1 Intervention
CARE + COACH is the CARE education module in addition to a COACH, which is access to an Apache paraprofessional women's health coach. The Coach functions like a patient navigator.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CARE
2019
N/A
~200
Find a Location
Who is running the clinical trial?
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
410 Previous Clinical Trials
2,106,580 Total Patients Enrolled
3 Trials studying Breast Cancer
3,899 Patients Enrolled for Breast Cancer
Allison Barlow, PhDPrincipal InvestigatorJohns Hopkins Bloomberg School of Public Health
5 Previous Clinical Trials
1,812 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not willing to be assigned to a treatment by chance.I am female.I have had breast cancer before.
Research Study Groups:
This trial has the following groups:- Group 1: CARE - Intervention arm for mammography education
- Group 2: CARE + COACH - Intervention arm for mammography education + a patient navigator
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers still soliciting volunteers for this research study?
"Confirmation from clinicaltrials.gov reveals that this medication trial has concluded its recruitment drive, which began on April 1st 2023 and ended December 19th 2022. Nevertheless, there are still over 2500 trials actively looking for participants to join their study."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger